
Balaxi Pharmaceuticals Share Price
₹68.76 -1.87 (-2.65%)
17 Mar, 2025 20:14
Start SIP in
BALAXI
Performance
- Low
- ₹68
- High
- ₹74
- 52 Week Low
- ₹50
- 52 Week High
- ₹151
- Open Price₹74
- Previous Close₹71
- Volume30,788
Investment Returns
- Over 1 Month + 14.3%
- Over 3 Month -15.97%
- Over 6 Month -37.42%
- Over 1 Year -27.67%
Smart Investing Starts Here Start SIP with Balaxi Pharmaceuticals for Steady Growth!
Balaxi Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.9
- PEG Ratio
- 0
- Market Cap Cr
- 380
- P/B Ratio
- 1.8
- Average True Range
- 5.34
- EPS
- 4.77
- Dividend Yield
- 0
- MACD Signal
- -0.71
- RSI
- 57.04
- MFI
- 15.06
Balaxi Pharmaceuticals Financials
Balaxi Pharmaceuticals Technicals
EMA & SMA
Current Price
₹68.76
-1.87
(-2.65%)

-
- Bearish Moving Average 7
-
- Bullish Moving Average 9
- 20 Day
- ₹64.34
- 50 Day
- ₹66.95
- 100 Day
- ₹74.55
- 200 Day
- ₹84.88
Resistance and Support
70.25
- R3 78.19
- R2 76.04
- R1 72.40
- S1 66.61
- S2 64.46
- S3 60.82
Balaxi Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-10 | Quarterly Results & Others | To consider other business matters. split from Rs. 10/- to Rs. 2/-. |
2024-11-05 | Quarterly Results & Others | To consider other business matters. split from Rs. 10/- to Rs. 2/-. |
2024-08-02 | Quarterly Results | |
2024-05-29 | Audited Results | |
2023-11-02 | Quarterly Results |
Balaxi Pharmaceuticals F&O
About Balaxi Pharmaceuticals
- NSE Symbol
- BALAXI
- BSE Symbol
- Managing Director
- Mr. Ashish Maheshwari
- ISIN
- INE618N01022
Similar Stocks to Balaxi Pharmaceuticals
Balaxi Pharmaceuticals FAQs
Balaxi Pharmaceuticals share price is ₹68 As on 17 March, 2025 | 20:00
The Market Cap of Balaxi Pharmaceuticals is ₹379.6 Cr As on 17 March, 2025 | 20:00
The P/E ratio of Balaxi Pharmaceuticals is 13.9 As on 17 March, 2025 | 20:00
The PB ratio of Balaxi Pharmaceuticals is 1.8 As on 17 March, 2025 | 20:00
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.